303 related articles for article (PubMed ID: 23614738)
21. Berberine downregulates CDC6 and inhibits proliferation via targeting JAK-STAT3 signaling in keratinocytes.
Sun S; Zhang X; Xu M; Zhang F; Tian F; Cui J; Xia Y; Liang C; Zhou S; Wei H; Zhao H; Wu G; Xu B; Liu X; Yang G; Wang Q; Zhang L; Gong Y; Shao C; Zou Y
Cell Death Dis; 2019 Mar; 10(4):274. PubMed ID: 30894513
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of the janus kinase family increases extracellular signal-regulated kinase 1/2 phosphorylation and causes endoreduplication.
Reiterer G; Yen A
Cancer Res; 2006 Sep; 66(18):9083-9. PubMed ID: 16982750
[TBL] [Abstract][Full Text] [Related]
23. Expression patterns of three JAK-STAT pathway genes in feather follicle development during chicken embryogenesis.
Tao Y; Zhou X; Liu Z; Zhang X; Nie Y; Zheng X; Li S; Hu X; Yang G; Zhao Q; Mou C
Gene Expr Patterns; 2020 Jan; 35():119078. PubMed ID: 31759166
[TBL] [Abstract][Full Text] [Related]
24. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.
Neilson LM; Zhu J; Xie J; Malabarba MG; Sakamoto K; Wagner KU; Kirken RA; Rui H
Mol Endocrinol; 2007 Sep; 21(9):2218-32. PubMed ID: 17550976
[TBL] [Abstract][Full Text] [Related]
25. Selective Immunomodulation of Inflammatory Pathways in Keratinocytes by the Janus Kinase (JAK) Inhibitor Tofacitinib: Implications for the Employment of JAK-Targeting Drugs in Psoriasis.
Morelli M; Scarponi C; Mercurio L; Facchiano F; Pallotta S; Madonna S; Girolomoni G; Albanesi C
J Immunol Res; 2018; 2018():7897263. PubMed ID: 30581877
[TBL] [Abstract][Full Text] [Related]
26. Structure of the pseudokinase-kinase domains from protein kinase TYK2 reveals a mechanism for Janus kinase (JAK) autoinhibition.
Lupardus PJ; Ultsch M; Wallweber H; Bir Kohli P; Johnson AR; Eigenbrot C
Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8025-30. PubMed ID: 24843152
[TBL] [Abstract][Full Text] [Related]
27. Inside-out and outside-in organotypic normal human skin culture: JAK-STAT pathway is activated after pro-inflammatory psoriatic cytokine exposure.
Cornaghi L; Gagliano N; Preis FWB; Prignano F; Donetti E
Tissue Cell; 2022 Feb; 74():101675. PubMed ID: 34781228
[TBL] [Abstract][Full Text] [Related]
28. Leptin stimulates interleukin-6 production via janus kinase 2/signal transducer and activator of transcription 3 in rheumatoid synovial fibroblasts.
Muraoka S; Kusunoki N; Takahashi H; Tsuchiya K; Kawai S
Clin Exp Rheumatol; 2013; 31(4):589-95. PubMed ID: 23622344
[TBL] [Abstract][Full Text] [Related]
29. CD109 release from the cell surface in human keratinocytes regulates TGF-β receptor expression, TGF-β signalling and STAT3 activation: relevance to psoriasis.
Litvinov IV; Bizet AA; Binamer Y; Jones DA; Sasseville D; Philip A
Exp Dermatol; 2011 Aug; 20(8):627-32. PubMed ID: 21539622
[TBL] [Abstract][Full Text] [Related]
30. Role and regulation of STAT3 phosphorylation at Ser727 in melanocytes and melanoma cells.
Sakaguchi M; Oka M; Iwasaki T; Fukami Y; Nishigori C
J Invest Dermatol; 2012 Jul; 132(7):1877-85. PubMed ID: 22418867
[TBL] [Abstract][Full Text] [Related]
31. Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha.
Doucet C; Giron-Michel J; Canonica GW; Azzarone B
Eur J Immunol; 2002 Sep; 32(9):2437-49. PubMed ID: 12207328
[TBL] [Abstract][Full Text] [Related]
32. Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells.
Agarwal C; Tyagi A; Kaur M; Agarwal R
Carcinogenesis; 2007 Jul; 28(7):1463-70. PubMed ID: 17341659
[TBL] [Abstract][Full Text] [Related]
33. Resokaempferol-mediated anti-inflammatory effects on activated macrophages via the inhibition of JAK2/STAT3, NF-κB and JNK/p38 MAPK signaling pathways.
Yu Q; Zeng K; Ma X; Song F; Jiang Y; Tu P; Wang X
Int Immunopharmacol; 2016 Sep; 38():104-14. PubMed ID: 27261558
[TBL] [Abstract][Full Text] [Related]
34. Selective JAK/STAT3 signalling regulates transcription of colony stimulating factor-2 and -3 in Concanavalin-A-activated mesenchymal stromal cells.
Zgheib A; Pelletier-Bonnier É; Levros LC; Annabi B
Cytokine; 2013 Aug; 63(2):187-93. PubMed ID: 23688618
[TBL] [Abstract][Full Text] [Related]
35. The granulocyte colony stimulating factor (G-CSF) activates Jak/STAT and MAPK pathways in a trophoblastic cell line.
Marino VJ; Roguin LP
J Cell Biochem; 2008 Apr; 103(5):1512-23. PubMed ID: 17879956
[TBL] [Abstract][Full Text] [Related]
36. Expression and localization of the activated mitogen-activated protein kinase in lesional psoriatic skin.
Yu XJ; Li CY; Dai HY; Cai DX; Wang KY; Xu YH; Chen LM; Zhou CL
Exp Mol Pathol; 2007 Dec; 83(3):413-8. PubMed ID: 17599830
[TBL] [Abstract][Full Text] [Related]
37. Activation of the interleukin-6/Janus kinase/STAT3 pathway in pleomorphic adenoma of the parotid gland.
Andreasen S; Therkildsen MH; Grauslund M; Friis-Hansen L; Wessel I; Homøe P
APMIS; 2015 Aug; 123(8):706-15. PubMed ID: 26061266
[TBL] [Abstract][Full Text] [Related]
38. The expression of dual-specificity phosphatase 1 mRNA is downregulated in lesional psoriatic skin.
Kjellerup RB; Johansen C; Kragballe K; Iversen L
Br J Dermatol; 2013 Feb; 168(2):339-45. PubMed ID: 22924482
[TBL] [Abstract][Full Text] [Related]
39. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
Zhu F; Dai C; Fu Y; Loo JF; Xia D; Gao SP; Ma Z; Chen Z
Oncotarget; 2016 Feb; 7(8):9462-76. PubMed ID: 26843613
[TBL] [Abstract][Full Text] [Related]
40. The YXXQ motif in gp 130 is crucial for STAT3 phosphorylation at Ser727 through an H7-sensitive kinase pathway.
Abe K; Hirai M; Mizuno K; Higashi N; Sekimoto T; Miki T; Hirano T; Nakajima K
Oncogene; 2001 Jun; 20(27):3464-74. PubMed ID: 11429693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
